Nanomedicine News

RSS

Non-Invasive, Molecular-Genetic Technique Using Nanoparticles for Imaging of Metastatic Cancer

Bioluminescence, nanoparticles, gene manipulation – these sound like the ideas of a science fiction writer, but, in fact, they are components of an exciting new approach to imaging local and metastatic tumors.

18 Sep 2014

3DNA Nanotechnology Platform Provider, Genisphere, Closes $2 Million in Private Funding

Genisphere LLC, provider of the 3DNA® nanotechnology platform, reported today it has closed $2 million in private funding from existing investors, including Corporate Fuel Partners, a New York fund. This round of fundraising will accelerate Genisphere's targeted drug delivery initiative, following key milestones including the company's demonstration of cell-specific (cytosolic and nuclear) delivery of drugs with functional intracellular effects without apparent toxicity.

17 Sep 2014

Novavax Begins Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 2 clinical trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate (RSV F Vaccine), in healthy women in the third trimester of pregnancy.

From Novavax Inc. 17 Sep 2014

Nanomedicine Company, Coldstream, Partners with CytImmune for CYT-6091 Phase II Trials

Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced a partnership with CytImmune to manufacture CYT-6091 for injection in preparation for Phase II clinical trials.

17 Sep 2014

CeloNova’s COBRA PzF Coronary Stent System with Polyzene-F Nano-Thin Coating Found to be Safe

CeloNova BioSciences, Inc., today announced that positive First-in-Man (FIM) clinical trial results found its COBRA PzF™ coronary stent system with an advanced nano-thin coating of Polyzene®-F polymer to be a safe and effective routine interventional treatment for real-world and complex patients with heart disease.

17 Sep 2014

Encouraging Preclinical Results from Study of Celator’s CPX-351 for Acute Lymphoblastic Leukemia

Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the publication of preclinical data in Pediatric Blood & Cancer that further characterize the therapeutic potential of lead compound CPX-351 in hematological malignancies and support its ongoing clinical testing in pediatric patients with ALL. CPX-351 is currently being studied in a pivotal Phase 3 clinical trial in older patients with high risk (secondary) AML.

16 Sep 2014

Immunotope Granted World-Wide License of CaPtivate's CaP Nanoparticle Technology

CaPtivate Pharmaceuticals LLC, a Pennsylvania-based biotechnology company developing calcium phosphate (CaP)-based nanoparticle drug and vaccine delivery technologies, announced today that the company has entered a License Agreement with Immunotope Inc., another Pennsylvania-based biotechnology company developing immunotherapy products for the treatment and prevention of viral infections and cancer.

16 Sep 2014

Blood-Cleansing Device Utilizes Modified Blood Proteins Coated on Magnetic Nanoparticles

Things can go downhill fast when a patient has sepsis, a life-threatening condition in which bacteria or fungi multiply in a patient's blood -- often too fast for antibiotics to help. A new device inspired by the human spleen and developed by a team at Harvard's Wyss Institute for Biologically Inspired Engineering may radically transform the way doctors treat sepsis.

16 Sep 2014

IMBED to Advance Polymeric Nanofilm Wound Healing Technology with Investment from WISC Partners

Strategic operating capital fund, Wisconsin Investment and Strategic Capital Partners (“WISC Partners”), has made the lead investment in Imbed Biosciences (“IMBED”) in order to advance the development and commercialization of their promising wound healing technology.

15 Sep 2014

Liposomes with Embedded Nanoparticles May Help Treat Cancer

In the race to find more effective ways to treat cancer, Boise State University biophysicist Daniel Fologea is working outside the rules of general mathematics that say one plus one equals two. In his world, one plus one adds up to a whole lot more.

12 Sep 2014

Nanomedicine News

Non-Invasive, Molecular-Genetic Technique Using Nanoparticles for Imaging of Metastatic Cancer

3DNA Nanotechnology Platform Provider, Genisphere, Closes $2 Million in Private Funding

Novavax Begins Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine

Nanomedicine Company, Coldstream, Partners with CytImmune for CYT-6091 Phase II Trials

CeloNova’s COBRA PzF Coronary Stent System with Polyzene-F Nano-Thin Coating Found to be Safe

Encouraging Preclinical Results from Study of Celator’s CPX-351 for Acute Lymphoblastic Leukemia

Immunotope Granted World-Wide License of CaPtivate's CaP Nanoparticle Technology

Blood-Cleansing Device Utilizes Modified Blood Proteins Coated on Magnetic Nanoparticles

IMBED to Advance Polymeric Nanofilm Wound Healing Technology with Investment from WISC Partners

Liposomes with Embedded Nanoparticles May Help Treat Cancer

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials